TCeliaTerrassa Profile Banner
Toni Celia-Terrassa Profile
Toni Celia-Terrassa

@TCeliaTerrassa

Followers
2K
Following
6K
Media
58
Statuses
2K

Leads the Cancer Stem Cells & Metastasis Lab @HMar_research | focused in breast cancer immunotherapy. Find me also here: @tceliaterrassa.bsky.social

Joined May 2016
Don't wanna be here? Send us removal request.
@deadoc80
Lorenzo Galluzzi
4 days
Happy to share our latest @trendscancer commentary on a @jclinicalinvest paper about #gammadeltaTcells and #radiotherapy #resistance in #cancer. Available at https://t.co/WkXvGiVynJ! Thanks to @TCeliaTerrassa for critical input and beautiful figure @FoxChaseCancer @hospitaldelmar
0
2
10
@LluisMontoliu
Lluis Montoliu
9 days
Ha muerto James Watson, premio Nobel de Fisiología o Medicina junto a Francis Crick y Maurice Wilkins en 1962 por descubrir la estructura del ADN a partir de datos de Rosalind Franklin, promotor de la secuenciación del genoma humano, autor de La doble hélice y rodeado de polémica
@nytimes
The New York Times
9 days
Breaking News: James Watson, who made one of the biggest breakthroughs in science by helping to discover the structure of DNA, died at 97.
4
114
318
@contracancerINV
Contra el Cáncer Investigación
28 days
🩷Hoy Día Mundial contra el Cáncer de Mama, queremos recordar cómo la investigación es clave para avanzar en su prevención, diagnóstico y tratamiento.🔬 Lee este artículo https://t.co/uTfrLMb79k y conoce cómo el Dr. @TCeliaTerrassa se enfrenta a los desafíos en la investigación
0
6
15
@ContraCancerSCT
Asociación Contra el Cáncer Santa Cruz de Tenerife
1 month
En el Día Mundial del Cáncer de Mama Metastásico, hablamos del apoyo que damos al equipo del Dr. Toni Celià-Terrassa (@TCeliaTerrassa), referente en cáncer de mama metastásico.
1
2
2
@mogijon
Mónica Álvarez Fernández
1 month
Beautiful talk from @TCeliaTerrassa at the innovation session in #ASEICAJovenRetreat2025 @ASEICAnews
0
5
15
@ASEICAnews
ASEICA
1 month
🔬💊 @TCeliaTerrassa, invited speaker of the ASEICA Joven Retreat. 🧬 His work is focused on breast cancer immunotherapy #ASEICACongress
0
3
12
@hps2002
Hector Peinado
1 month
@ASEICAnews is a great environment to discuss science and find friends! so happy to keep in contact and have generated "ASEICA Viejoven" 😘 #aseicacongress @TheAnaJanic @mogijon @PamplonaSanz @MariaCaffarel @VTorranoMoya @J_RodriguezVita @TCeliaTerrassa @calvo_lab @psancholab
@psancholab
Psancholab
1 month
Getting together with my peers at #aseicacongress !! So excited!!
0
8
26
@psancholab
Psancholab
1 month
Getting together with my peers at #aseicacongress !! So excited!!
1
8
22
@HMar_research
HMar Research Institute
2 months
👉S'acosta la Nit de la Recerca 2025 El Dr. @TCeliaTerrassa participa en la taula rodona organitzada per la @FundacionFero 🗓️ 26/9 ⏰ 18 h 📍Biblioteca Gabriel García Márquez Inscripció gratuïta https://t.co/JkOLbRRV46 @VHIO @rubenvent #NitRecerCat #NitRecerCAT25
0
4
5
@Ludwig_Cancer
Ludwig Cancer
2 months
Researchers led Ludwig @Princeton's Yujiao Han & @yibinkang have discovered how metastatic breast cancer cells employ mimicry and manipulation to thrive in the low-oxygen microenvironment of bone marrow—& how this trickery likely causes anemia in patients. https://t.co/u22mcAjpKr
7
9
18
@TCeliaTerrassa
Toni Celia-Terrassa
3 months
Great commentary summarizing new roles of γδTcells in BC: resistance to CDK4/6 inhibitors in hormone receptor (HR)+ breast cancer; and Metastasis Initiation.
@ClaudiaGalassi9
Claudia Galassi, PhD
3 months
Happy to share our latest commentary on #IL17γδTcells and TIM-3⁺ metastases in #TNBC, just published in @embojournal! free here 👉 https://t.co/odasXhrUEw @deadoc80 @FoxChaseCancer @WeillCornell
0
1
5
@deadoc80
Lorenzo Galluzzi
3 months
@ClaudiaGalassi9 @embojournal @FoxChaseCancer @WeillCornell On a wonderful original article from @TCeliaTerrassa and colleagues published not long ago in @Cancer_Cell
0
2
5
@ClaudiaGalassi9
Claudia Galassi, PhD
3 months
Happy to share our latest commentary on #IL17γδTcells and TIM-3⁺ metastases in #TNBC, just published in @embojournal! free here 👉 https://t.co/odasXhrUEw @deadoc80 @FoxChaseCancer @WeillCornell
embopress.org
1
4
11
@msmelanoma
Marisol Soengas
4 months
Emoción a flor de piel! GRACIAS, @manuelansede por cómo has resumido tanto esfuerzo detrás del desarrollo científico y empresarial de BO-112, pero también por ese “en primera persona” de lo que suponen nuevos tratamientos para los pacientes https://t.co/dwe3sigzOV vía @el_pais
Tweet card summary image
elpais.com
La líder científica, la empresaria y una paciente libre de enfermedad se reúnen para contar la historia completa del prometedor fármaco experimental español contra los tumores
3
25
67
@deadoc80
Lorenzo Galluzzi
4 months
@TCeliaTerrassa @Cancer_Cell Same week, two independent papers on the negative impact of IL17 and gammadelta T cells on #BreastCancer! Congrats @TCeliaTerrassa @NatureCancer @Cancer_Cell @NatureRevCancer @NatImmunol @trendscancer @TrendsImmuno Ours at https://t.co/clTKQnNiGQ!
0
2
7
@FundacionFero
Fundación Fero
4 months
El II Proyecto FERO-MANGO del Dr. Toni Celià-Terrassa ha sido publicado en Cancer Cell, una de las revistas científicas más prestigiosas del mundo. Desde FERO celebramos con orgullo este importante logro. ¡Enhorabuena a todo el equipo del Dr. @TCeliaTerrassa!
2
7
27
@TCeliaTerrassa
Toni Celia-Terrassa
4 months
1
0
6
@TCeliaTerrassa
Toni Celia-Terrassa
4 months
Highlights •Immune pressure selects TIM3+ tumor cells during micrometastasis •TIM3+ tumor cells exhibit stemness, EMT, and immune-evasive features •TIM3 in tumor cells is a biomarker of poor prognosis •(Neo)adjuvant TIM3 blockade prevents metastatic seeding and outgrowth
1
1
5
@TCeliaTerrassa
Toni Celia-Terrassa
4 months
We’re thrilled to share our latest publication in @Cancer_Cell, and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis
cell.com
Rozalén et al. report that TIM3 in breast cancer drives a specific mechanism of immune escape during micrometastasis. TIM3+ tumor cells exhibit stemness/EMT features and promote immune-evasion by...
26
26
130
@Aiims1742
Anirban Maitra
6 months
Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning
6
66
258